D-Ribose Gains EFSA Novel Food Safety Authorization


Bioenergy Life Science predicts robust activity for the energy ingredient.

The European Food and Safety Authority (EFSA) has published the novel food authorization for Bioenergy Ribose, allowing formulators to use the clinically proven energy ingredient in nutritional foods and beverages sold in Europe. This novel food authorization is in addition to D-ribose’s use in dietary supplements, which is grandfathered in with a much higher allowable dose.
“Earning novel food authorization, especially in the energy category, is reason to celebrate! Many major companies have been eagerly anticipating this approval,” confirmed Bioenergy Life Science CEO and Chairman Leo Zhang. “This is also great news for international companies already using Bioenergy Ribose in the U.S., as they can now use it in their European formulations. We expect to see functional foods and beverages made with Bioenergy Ribose to reach European consumers very quickly.” 
In its novel foods confirmation, EFSA wrote: “The main source of intake of the novel food from the proposed uses were: fine bakery wares, the highest contributors in all population groups; milk drinks, high contributors in all population groups apart from infants; and sports, isotonic and energy drinks, which were high contributors in adolescents, adults and the elderly.” The panel noted that the acceptable level of intake is 36mg/kg of body weight per day. However, the level in dietary supplements exceeds this limit. 
“This was a long time coming. Achieving a place on the EFSA novel foods list requires a rigorous approval process. This is an important milestone for our company. We are gratified that the panel agreed with the significant science we submitted demonstrating the benefits and safety of Bioenergy Ribose,” commented Bioenergy Life Science Director of Marketing Penny Portner. She noted that Bioenergy Ribose has a five-year novel food exclusivity. 
Bioenergy Ribose Clinically Proven to Increase ATP 
Bioenergy Ribose, a 5-carbon monosaccharide, works by regulating the body’s natural energy synthesis. It helps muscles regenerate lost energy, and to reduce muscle soreness. Think of it as helping to level your body’s energy supply versus its demand for energy. 
“We are already receiving a lot of positive feedback from formulators who can finally use Bioenergy Ribose. When you think of energy, most people think of a variation of caffeine or other form of stimulant. Bioenergy Ribose supplies sustainable cellular energy with no crash,” explained Bioenergy Life Science Executive Vice President and Chief Scientific Officer Alex Xue, PhD. “Ribose is naturally present in every living cell but the process to produce it is very slow, especially in the heart and muscle tissues. Bioenergy Ribose drives the process that replenishes ATP and other energy components.” He added that athletes frequently seek increased levels of ATP to produce sustained cellular energy for strength, power and/or endurance. Increased ATP also helps non-athletic individuals adapt to physical activities or exercise (Journal of International Society of Sports Nutrition, 2017).
Bioenergy Ribose has more than 30 issued or pending patents, and its benefits are documented by more than 110 clinical studies. Its safety is evidenced by its GRAS status (including a “no questions letter” from the FDA). Bioenergy Ribose also meets or exceeds many quality standards that include Grade-A Level Certification from the BRC and kosher certification. It’s also non-GMO and gluten-free.